Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Asceletis, Recce.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Astellas, Carsgen, Caliway, Radiopham.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Equillium, Kura Oncology.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Adagene, Alerity, Ascletis, Merck, Recce, Taiho.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Bio-Thera Solutions, Hengrui, Kailera, Zai Lab.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Technoderma.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Hanx, Xgene.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ena Respiratory, Immunabs, Immutep, Microbio.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Caliway, Dizal, Immutep.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Astrazeneca, Cynata Therapeutics, Everest, Hua Medicine, Inventisbio, MEsoblast Vasomune Therapeutics.